Home » Topics » BioWorld Science

BioWorld Science
RSS

Purified or recombinant protein for HIV infection and cancer offered for licensing

Nov. 26, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Nov. 26, 1996

Worldwide rights offered for protein inducing oligodendroglia mitosis

Nov. 26, 1996

Tularik receives patent coverage relating to drug discovery efforts

Nov. 26, 1996

Cambridge NeuroScience/Allergan ophthalmic disease collaboration

Nov. 26, 1996

Rx for Sjogren's syndrome symptoms nearing launch

Nov. 26, 1996

Novel antipsychotic drug now available in U.K.

Nov. 26, 1996

VIMRx and Innovir to combine operations

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...